Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma.
NPJ Precis Oncol
; 6(1): 61, 2022 Sep 02.
Article
in En
| MEDLINE
| ID: mdl-36056177
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
NPJ Precis Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: